Skip to content
Home/Companies/Biotech/Nephris
NE

Nephris

Biotech·Italy·Active·4yr hold

Nephris is a healthcare / biotech company, headquartered in Italy.

Entry
2022
Hold
4yr
Status
Active
Est. EV
–

Who owns Nephris?

Nephris is currently owned by Sofinnova Partners through Sofinnova Telethon (2016 vintage), since 2022.

Hand-verified · updated 2026-04-21

Sofinnova Partners
Investor
Sofinnova Partners
Sofinnova Telethon · 2016 · Life Sciences VC

Key facts

HQItaly
SectorHealthcare / Biotech

More from Sofinnova Telethon

Other portfolio companies in the same fund.

nChroma (formerly Chroma Medicine)
Active
BiotechUS· 2022
Alia Therapeutics
Active
BiotechItaly· 2021
Borea Therapeutics
Active
BiotechItaly· 2021
AAVantgarde Bio
Active
BiotechItaly· 2020

More PE-backed in Biotech

Comparable biotech deals from other GPs.

InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings